Date | Time | Source | Announcement |
---|---|---|---|
24 Oct 2002 | 08:59 AM | New Development Partner | |
19 Sep 2002 | 03:02 PM | Director Shareholding | |
17 Sep 2002 | 12:16 PM | Director Shareholding | |
11 Sep 2002 | 03:26 PM | Director Shareholding | |
29 Aug 2002 | 03:35 PM | Director Shareholding | |
28 Aug 2002 | 07:00 AM | Interim Results | |
27 Aug 2002 | 04:10 PM | Holding(s) in Company | |
13 Aug 2002 | 11:28 AM | Notice of Results | |
06 Aug 2002 | 03:48 PM | Holding(s) in Company | |
25 Jul 2002 | 09:23 AM | Re Agreement | |
11 Jul 2002 | 07:00 AM | Positive Clinical Trials | |
27 Jun 2002 | 03:10 PM | Holding(s) in Company | |
25 Jun 2002 | 07:00 AM | Research Update | |
10 Jun 2002 | 07:00 AM | Research Update | |
06 Jun 2002 | 07:00 AM | Statement re: product update | |
08 May 2002 | 07:00 AM | Re Alliance | |
01 May 2002 | 11:57 AM | Directorate Change | |
20 Mar 2002 | 04:08 PM | Annual Report & Accts etc | |
27 Feb 2002 | 07:00 AM | Final Results | |
20 Feb 2002 | 02:30 PM | Research Update | |
22 Jan 2002 | 11:09 AM | Blocklisting Interim Review | |
15 Jan 2002 | 02:57 PM | Notice of Results | |
24 Dec 2001 | 11:57 AM | Director Shareholding | |
13 Dec 2001 | 07:00 AM | Research Update/Issue of Shrs | |
12 Nov 2001 | 07:00 AM | Research Update | |
01 Nov 2001 | 02:52 PM | Director Shareholding | |
15 Oct 2001 | 07:00 AM | Research Update | |
02 Oct 2001 | 11:00 AM | Termination of collaboration | |
12 Sep 2001 | 09:34 AM | Holding in Company | |
06 Sep 2001 | 10:31 AM | Hldg in Co/D. Shareholding | |
01 Aug 2001 | 07:01 AM | Interim Results | |
27 Jul 2001 | 04:39 PM | Notice of Results | |
10 Jul 2001 | 10:41 AM | Research Update | |
26 Jun 2001 | 01:44 PM | Statement re Patent | |
29 May 2001 | 05:28 PM | Holding in Company | |
29 May 2001 | 02:19 PM | Director Shareholding | |
29 May 2001 | 01:09 PM | Appointment | |
02 May 2001 | 05:56 PM | Additional Listing | |
24 Apr 2001 | 11:02 AM | Re Techmark Index | |
17 Apr 2001 | 04:20 PM | Completion of Fund Raising | |
17 Apr 2001 | 01:55 PM | Document regarding Listing Particulars | |
17 Apr 2001 | 07:00 AM | Results of EGM &Equity Issues | |
27 Mar 2001 | 07:00 AM | Successful patent application | |
12 Mar 2001 | 05:10 PM | Director Shareholding | |
12 Mar 2001 | 07:01 AM | Corporate Action | |
12 Mar 2001 | 07:01 AM | Full List/Placing& Open Offer | |
14 Feb 2001 | 03:59 PM | Additional Listing | |
13 Feb 2001 | 10:48 AM | Appointment | |
05 Feb 2001 | 07:00 AM | Acquisition of Technology | |
01 Feb 2001 | 04:35 PM | Access to Antibody Technology |
Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.
Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.
Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.